| Sarah Marie Kennedy, PTA | |
|
6080 Southwest Blvd, Benbrook, TX 76109 | |
| (817) 731-9331 | |
| (817) 731-9882 |
| Full Name | Sarah Marie Kennedy |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 6080 Southwest Blvd, Benbrook, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326298985 | NPI | - | NPPES |
| 2067489 | Other | TX | TEXAS LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 2067489 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Marie Kennedy, PTA 6080 Southwest Blvd, Cooper & Bush Physical Therapy, Benbrook, TX 76109 Ph: (817) 731-9331 | Sarah Marie Kennedy, PTA 6080 Southwest Blvd, Benbrook, TX 76109 Ph: (817) 731-9331 |
News Archive
Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.
Women's bodies are different from men's. We need more knowledge to better understand women's health, says medical doctor and Professor Johanne Sundby. She finds support in a new report on the same topic.
Norman H. Lee, Ph.D., professor of pharmacology at the George Washington University School of Medicine and Health Sciences (SMHS), received a total of $405,001 in grant funding from the National Institute on Drug Abuse (NIDA) to continue to study the correlation between genetics and susceptibility to drug abuse.
Researchers from Cleveland Clinic's Wellness Institute and Harvard University have found that greater consumption of sugar-sweetened and low-calorie sodas is associated with a higher risk of stroke. Conversely, consumption of caffeinated or decaffeinated coffee was associated with a lower risk.
Oncologists at the Fred Hutchinson Cancer Research Center have successfully treated a patient with metastatic melanoma by combining two different types of immunotherapy. Cassian Yee and colleagues describe their approach in a paper, "Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient," that will be published online May 30 in The Journal of Experimental Medicine.
› Verified 4 days ago